Synapse Open Synapse
Biology

Overcoming Bottlenecks: Biopharma’s Big Challenge Is Execution

GEN · · 5 min read

The biggest challenge facing the biopharma industry isn’t scientific innovation. It’s manufacturing execution. Closing this gap is one of the greatest opportunities biopharma has today to enhance resilience and unlock the full value of its science.

Latest from GEN